NCT05106244 2024-04-03
RRTGS
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
Clinical Trials
85 trialsNCT05767697 2024-03-26
Genomics and Prognosis in GI Cancers
National Health Research Institutes, Taiwan
Unknown
NCT06301828 2024-03-08
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Nanjing First Hospital, Nanjing Medical University
Phase 2 Unknown
NCT05226221 2024-02-07
GESEMM
Campus Bio-Medico University
Unknown
NCT04883970 2024-01-25
CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT06199115 2024-01-10
Prevention of Neuropathic Pain From Oxaliplatin by Photobiomodulation
Saint-Gregoire Private Hospital Center
Phase NA Unknown
NCT06152419 2024-01-05
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
University Hospital, Ghent
Phase NA Unknown
NCT02428101 2023-11-28
Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer
Ain Shams University
Unknown
NCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown
NCT05159479 2023-09-21
Defining Robust Predictors of Chemotherapy Related Cardiotoxicity
University College, London
Unknown
NCT05837598 2023-08-03
Adapting the Tumor Board Model for Mental Illness and Cancer
Massachusetts General Hospital
Phase NA Unknown
NCT05830292 2023-07-25
Use of DRS Probe and Tracking for In-vivo Application
Imperial College London
Phase NA Unknown
NCT05420558 2023-07-17
Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
Zhongnan Hospital
Unknown
NCT05937919 2023-07-10
68Ga-PMD22 PET/CT Examination Targeting CLDN18.2
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT05051358 2023-05-26
TEUS Registry
Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University
Unknown
NCT05788874 2023-04-14
Study of 18F-FAPI Applied to Gastrointestinal Cancer
First Affiliated Hospital Xi'an Jiaotong University
Unknown
NCT03602677 2023-03-27
ICG-COLORAL
Oulu University Hospital
Phase NA Unknown
NCT05429866 2023-03-08
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
Phase 2 Unknown
NCT05693519 2023-01-23
GICCA
Leiden University Medical Center
Unknown
NCT05559775 2022-09-29
A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT05552729 2022-09-23
Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors
Yangzhou University
Phase 1/2 Unknown
NCT05494320 2022-08-09
the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin
Ain Shams University
Unknown
NCT02196935 2022-06-15
Los Angeles Prospective GI Biliary and EUS Series
University of Southern California
Unknown
NCT04611035 2022-04-06
Q-GAIN (Using Qpop to Predict Treatment for GAstroIntestinal caNcer)
National University Hospital, Singapore
Unknown
NCT05232357 2022-03-15
Endoscopic Vital Nerve Staining in Gastrointestinal Diseases
Affiliated Hospital to Academy of Military Medical Sciences
Phase EARLY_PHASE1 Unknown
NCT05280210 2022-03-15
PTC in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal Tumor
Peking University
Phase NA Unknown
NCT05225844 2022-02-07
An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal
Harbin Medical University
Phase 2 Unknown
NCT05030363 2022-01-11
ALDHCRF
Korea University Anam Hospital
Phase NA Unknown
NCT02595320 2021-12-20
X7-7
University of Kansas Medical Center
Phase 2 Unknown
NCT05141617 2021-12-02
Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT03670199 2021-09-13
PENDICOQ
University Hospital, Strasbourg, France
Phase NA Unknown
NCT04905329 2021-06-02
Def_Special
Moscow Clinical Scientific Center
Unknown
NCT04393584 2021-04-13
RusGCG-01
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
NCT04774679 2021-03-01
Macroscopic on Cite Evaluation of EUS-FNA Specimen With 22 G Needle
Kocaeli University
Phase NA Unknown
NCT04709055 2021-01-19
IMPROVED
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT04709445 2021-01-14
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
Charite University, Berlin, Germany
Phase NA Unknown
NCT02837679 2020-04-29
Oncogeriatric Intervention and Follow-up at Home
University of Aarhus
Phase NA Unknown
NCT03502317 2020-02-27
PICaSO
Mount Sinai Hospital, Canada
Phase NA Unknown
NCT04202848 2019-12-18
The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients
The First Affiliated Hospital of Dalian Medical University
Unknown
NCT04189393 2019-12-06
MA-PPING
Radboud University Medical Center
Unknown
NCT03699332 2019-09-13
MMIPC
Radboud University Medical Center
Phase 1/2 Unknown
NCT04069975 2019-08-30
Sedation Versus No Sedation for Detection Rates of Precancerous Lesions and Cancer
Shandong University
Unknown
NCT04071431 2019-08-28
A Questionnaire for Endoscopic Prediction Improvement of Gastrointestinal Cancer
Shandong University
Phase NA Unknown
NCT03862378 2019-06-11
APPEAL-GC
Peking University
Unknown
NCT02349958 2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2 Unknown
NCT03915171 2019-04-16
Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer
China Medical University, China
Phase NA Unknown
NCT03889626 2019-03-26
The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer
Fudan University
Phase 3 Unknown
NCT03812796 2019-02-05
EMERGE
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT03828266 2019-02-04
PACAGE
Peking University
Unknown
NCT03271255 2019-01-23
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
Shenzhen People's Hospital
Phase 2 Unknown